Author:
Ajkay Nicolas,Collett Abigail E.,Bloomquist Erica V.,Gracely Edward J.,Frazier Thomas G.,Barrio Andrea V.
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Pawlik TM, Bucholz TA, Kuerer HM. The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg. 2004;199:479-92.
2. Czechura T, Winchester DJ, Pesce C, Huo D, Winchester DP, Yao K. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the national cancer data base. Ann Surg Oncol. 2013;20(10):3223-32.
3. Smith GL, Xu Y, Buchholz TA, et al. Association between treatment with brachytherapy versus whole-breast irradiation and subsequent mastectomy, complications and survival among older women with invasive breast cancer. JAMA. 2012;307:1827-37.
4. Chao KK, Vicini FA, Wallace M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial breast irradiation: the William Beaumont hospital experience. Int J Radiat Oncol Biol Phys. 2007:69:32-40.
5. Radiation Therapy Oncology Group. NSABP Protocol B-39/RTOG Protocol 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Available from: www.rpc.mdanderson.org/rpc/credentialing/files/B39_Protocol1.pdf . Accessed 1 Feb 2014.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献